Similar articles for PMID: 22068564

Year	Number of Results
1979	1
1985	1
1993	1
1994	5
1995	4
1996	2
1997	3
1999	4
2000	2
2001	2
2002	4
2003	3
2004	4
2005	2
2006	3
2007	6
2008	1
2009	3
2010	12
2011	8
2012	3
2013	8
2014	4
2015	3
2016	7
2017	3
2018	9
2019	1
2020	7
2021	5
2023	2
2024	1
2025	0

1

The SNM practice guideline for somatostatin receptor scintigraphy 2.0.

Balon HR, Brown TL, Goldsmith SJ, Silberstein EB, Krenning EP, Lang O, Dillehay G, Tarrance J, Johnson M, Stabin MG; Society of Nuclear Medicine. Balon HR, et al. J Nucl Med Technol. 2011 Dec;39(4):317-24. doi: 10.2967/jnmt.111.098277. Epub 2011 Nov 8. J Nucl Med Technol. 2011. PMID: 22068564 Free article. No abstract available.

2

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide.

Kwekkeboom DJ, Krenning EP, Scheidhauer K, Lewington V, Lebtahi R, Grossman A, Vitek P, Sundin A, Plöckinger U; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society. Kwekkeboom DJ, et al. Neuroendocrinology. 2009;90(2):184-9. doi: 10.1159/000225946. Epub 2009 Aug 28. Neuroendocrinology. 2009. PMID: 19713709 No abstract available.

3

[Somatostatin receptor scintigraphy].

Rasmussen K, Nielsen JT, Rehling M. Rasmussen K, et al. Ugeskr Laeger. 2005 Dec 5;167(49):4647-50. Ugeskr Laeger. 2005. PMID: 16336855 Danish.

4

Somatostatin receptor imaging with (111)In-pentetreotide in gastro-intestinal tract and lung neuroendocrine tumors-Impact on targeted treatment.

Gerasimou G, Moralidis E, Gotzamani-Psarrakou A. Gerasimou G, et al. Hell J Nucl Med. 2010 May-Aug;13(2):158-62. Hell J Nucl Med. 2010. PMID: 20808990 Review.

5

Updated practice guideline for somatostatin receptor scintigraphy.

Balon HR. Balon HR. J Nucl Med. 2011 Dec;52(12):1838. doi: 10.2967/jnumed.111.098285. Epub 2011 Nov 8. J Nucl Med. 2011. PMID: 22068893 Free article. No abstract available.

6

The SNM practice guideline on hepatobiliary scintigraphy.

Tulchinsky M. Tulchinsky M. J Nucl Med. 2010 Dec;51(12):1825. doi: 10.2967/jnumed.110.084475. J Nucl Med. 2010. PMID: 21098793 Free article. No abstract available.

7

Clinical relevance of somatostatin receptor imaging.

Reubi JC. Reubi JC. Eur J Endocrinol. 1994 Dec;131(6):575-6. doi: 10.1530/eje.0.1310575. Eur J Endocrinol. 1994. PMID: 7804438 No abstract available.

8

Somatostatin Receptor Scintigraphy: Blazing in Indium and Quenching in Gallium.

Bodei L. Bodei L. J Nucl Med. 2020 Dec;61(Suppl 2):121S-122S. doi: 10.2967/jnumed.120.251934. J Nucl Med. 2020. PMID: 33293432 Free article. No abstract available.

9

Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours.

Slooter GD, Mearadji A, Breeman WA, Marquet RL, de Jong M, Krenning EP, van Eijck CH. Slooter GD, et al. Br J Surg. 2001 Jan;88(1):31-40. doi: 10.1046/j.1365-2168.2001.01644.x. Br J Surg. 2001. PMID: 11136306 Review.

10

Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide.

Balon HR, Goldsmith SJ, Siegel BA, Silberstein EB, Krenning EP, Lang O, Donohoe KJ; Society of Nuclear Medicine. Balon HR, et al. J Nucl Med. 2001 Jul;42(7):1134-8. J Nucl Med. 2001. PMID: 11438641 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 22068564

119 results

Results by year